selected scholarly activity
-
conferences
- Development and validation of a prognostic survival model with patient reported outcomes for older adults with multiple myeloma. Clinical Lymphoma, Myeloma and Leukemia. S24-S24. 2023
- Insulin Resistance and Its Association with Phospholipid Profile, Carotid Intimal-Medial Thickness and Carotid Plaque Area in Women with Systemic Lupus Erythematosus. Arthritis and Rheumatism. S889-S890. 2011
- Is Dietary Intake of Patients with Systemic Lupus Erythematosus Adequate?. Arthritis and Rheumatism. S1038-S1038. 2011
- The Role of Fatty Acid Composition in Antiphospholipid Syndrome and Systemic Lupus Erythematosus. Arthritis and Rheumatism. S8-S9. 2011
-
journal articles
- Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study.. Hematology Journal. 2024
- Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy. BMC Cancer. 24:984. 2024
- Patient-Reported Outcome Measures in Cancer Care. JAMA network open. 7:e2424793-e2424793. 2024
- Oncologists’ Satisfaction with Virtual Care: A Questionnaire. Current Oncology. 31:3269-3277. 2024
- A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma. Oncologist. 29:519-526. 2024
- COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies. Vaccine. 42:126074. 2024
- Comparison of the Efficacy in Clinical Trials Versus Effectiveness in the Real-World of Treatments for Multiple Myeloma: A Population-Based Cohort Study. Blood. 142:541-541. 2023
- OA-39 Development and validation of a prognostic survival model with patient reported outcomes for older adults with multiple myeloma. Clinical Lymphoma, Myeloma and Leukemia. 23:S24-S24. 2023
- Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphomas. Blood. 140:8036-8037. 2022
-
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (
PROMs ). European Journal of Haematology. 109:3-9. 2022 - Transfusion thresholds in myelodysplastic syndrome—Helping patients live better. Transfusion. 62:1313-1314. 2022
- Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study. Blood Cancer Journal. 12:17. 2022
- Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes. Clinical Lymphoma, Myeloma and Leukemia. 21:e714-e721. 2021
- External validation of the FIRST trial’s simplified frailty score in a population-based cohort. Leukemia. 35:1823-1827. 2021
- Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy. Transfusion. 61:286-293. 2021
- Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis. European Journal of Haematology. 105:626-634. 2020
- Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score. Blood. 132:2684-2686. 2018
- The Use of Anticoagulation in Patients With Thrombocytopenia. Blood. 15. 2018
- Testosterone use causing erythrocytosis. CANADIAN MEDICAL ASSOCIATION JOURNAL. 189:E1286-E1288. 2017
- Refractory Hypercalcemia in a Jamaican Woman. Canadian Journal of General Internal Medicine. 11. 2016
- Factors Affecting Attendance at an Adapted Cardiac Rehabilitation Exercise Program for Individuals with Mobility Deficits Poststroke. Journal of Stroke and Cerebrovascular Diseases. 25:87-94. 2016
- Enteropathy-Associated T-Cell Lymphoma: A Single Centre Experience. Blood. 126:5057-5057. 2015
- Thrombovascular Events Affect Quality of Life in Patients with Systemic Lupus Erythematosus. Journal of Rheumatology. 38:1017-1019. 2011
- When Pruritus is Not Allergy: Appropriate Signs of Lymphoma and Other Malignancies for the Community Allergist
-
preprints